Portfolio company Vytrus Biotech listed on BME Growth, debuting with an implied EUR12.2M valuation.
Vytrus Biotech creates high added value natural active ingredients on an industrial scale through an innovative and unique process in the biotechnology field which obtains the real power of nature
Vytrus Biotech creates high added value natural active ingredients on an industrial scale through an innovative and unique process in the biotechnology field which obtains the real power of nature.